|
KMID : 1161420210240121280
|
|
Journal of Medicinal Food
2021 Volume.24 No. 12 p.1280 ~ p.1284
|
|
|
The Effect of Ankaferd Blood Stopper on Colonic Inflammation: An In Vitro Study in RAW 264.7 and Caco-2 Cells
|
|
Alyamac Aysegul
Ozel-Tasci Cansu
Gulec Sukru
|
|
|
Abstract
|
|
|
|
Ankaferd Blood Stopper (ABS) is a medicinal plant extract that has anti-inflammatory effect. Inflammatory bowel disease is a pathological condition that directly affects colon health and increases the risk of colon cancer. Especially inflammation is an important factor in the formation and progression of this disease. The aim of the study was to investigate the protective effect of ABS on colonic inflammation. Caco-2 and RAW 264.7 cells were used as a model of in vitro colonic inflammation. RAW 264.7 cells were treated with lipopolysaccharide for 12?h to induce inflammation, and an inflammatory medium (IM) was obtained. Caco-2 cells were treated with 15?μL/mL ABS for 4?h, then incubated with IM. The cells also were incubated with 15?μL/mL ABS and IM together for 12?h. Tumor necrosis factor alpha (TNF-α) protein levels were targeted in testing inflammatory condition and cyclooxygenase-2 (COX-2) mRNA level was used as a marker gene to show the possible anti-inflammatory effect of ABS in Caco-2 cells. TNF-α level was 26.1-fold higher than the control group. IM caused 3.2-fold increase in COX-2 expression in Caco-2 cells. Pretreatment of Caco-2 cells with ABS resulted in 3.3-fold decrease in COX-2 mRNA levels relative to IM group. Furthermore, COX-2 mRNA level reduced 4.7-fold when ABS and conditional medium were given at the same time. ABS has suppressive effect on COX-2 mRNA expression in Caco-2 cells. These results suggest that ABS might have protective and therapeutic effect for colonic inflammation.
|
|
|
KEYWORD
|
|
|
Ankaferd Blood Stopper, Caco-2, cyclooxygenase-2, inflammation, RAW 264.7, tumor necrosis factor alpha
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|